Jump to content

Talk:Mitragyna speciosa

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 65.183.175.130 (talk) at 18:05, 8 August 2019 (→‎US legal sales status: new section). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.


Biased

Over 20 observational studies published in respected, peer reviewed journals are excluded presumably because they do not fit the narrative. These are authored by Oliver Grundmann, Darshan Singh, Marc Swogger, Jack Henningfield, and others and refute some of the information spouted by non-scientific sources. Mako7717 (talk) 14:33, 23 July 2019 (UTC)[reply]

Mako7717: There is no bias, but rather objectivity based on reviews and government regulations. This is an encyclopedia, not a manual or journal article collating the primary research on kratom; WP:NOTMANUAL #6-8. See the left pyramid at WP:MEDASSESS: observational studies are early-stage, inconclusive, primary research. It is difficult - if not impossible - to conduct thorough, high-quality clinical research on kratom because (as a natural compound) it cannot be patented and remains under restrictive control in most countries, meaning there is no source of the substantial funding needed for the high cost of clinical trials. We rely on the best available reviews in reputable journals. You can add them, if they are not present already. --Zefr (talk) 14:55, 23 July 2019 (UTC)[reply]

The citation does not back up the claim that the sale of kratom is illegal in the United States. It does not even deal with the topic, being an FDA letter that is talking about the legality of making specific health claims about kratom. The FDA doesn't ban drugs, the DEA does. 65.183.175.130 (talk) 18:05, 8 August 2019 (UTC)[reply]